Cargando…
Discovery of human-like L-asparaginases with potential clinical use by directed evolution
L-asparaginase is a chemotherapy drug used to treat acute lymphoblastic leukemia (ALL). The main prerequisite for clinical efficacy of L-asparaginases is micromolar K(M) for asparagine to allow for complete depletion of this amino acid in the blood. Since currently approved L-asparaginases are of ba...
Autores principales: | Rigouin, Coraline, Nguyen, Hien Anh, Schalk, Amanda M., Lavie, Arnon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579231/ https://www.ncbi.nlm.nih.gov/pubmed/28860480 http://dx.doi.org/10.1038/s41598-017-10758-4 |
Ejemplares similares
-
Structural and Kinetic Characterization of Guinea
Pig l-Asparaginase
Type III
por: Schalk, Amanda M., et al.
Publicado: (2014) -
Structural Insight into Substrate Selectivity of Erwinia chrysanthemil-Asparaginase
por: Nguyen, Hien Anh, et al.
Publicado: (2016) -
The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity
por: Nguyen, Hien Anh, et al.
Publicado: (2017) -
P320: A NOVEL MAMMALIAN L-ASPARAGINASE WITH NO L-GLUTAMINASE ACTIVITY IS HIGHLY EFFICACIOUS AGAINST T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VIVO
por: Van Trimpont, Maaike, et al.
Publicado: (2023) -
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
por: Van Trimpont, Maaike, et al.
Publicado: (2022)